national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
Press Release: Douglas Brown, MHS, Deputy Director, Data Sharing & Partnership Group (DSPG), Center for Program Integrity, Centers for Medicare & Medicaid Services, Newly Confirmed to Keynote the Sixth Annual Summit on Disclosure for Drug, Device & Biotech Companies
  • A Hybrid Conference, Internet Event and Training Tool
  • The Leading Forum on Disclosure, Transparency and Aggregate Spend for Drug, Device and Biotech Companies
  • Sponsored by Pharmaceutical Compliance Forum
  • February 5 - 7, 2014
  • Onsite at the Hyatt Regency Crystal City in Washington, DC
  • Online In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
  • www.DisclosureSummit.com
PRESS RELEASE
Phone: 800-503-0112
Email: registration@hcconferences.com
Website: www.DisclosureSummit.com
KEYNOTE ADDRESS BY



Douglas Brown, MHS
Deputy Director, Data Sharing & Partnership Group (DSPG), Center for Program Integrity, Centers for Medicare & Medicaid Services, Baltimore, MD

WASHINGTON DC USA -- PHARMA UPDATE NEWS SERVICE™ -- JANUARY 13, 2014: The Sixth Annual Summit on Disclosure for Drug, Device and Biotech Companies, www.DisclosureSummit.com, will be held February 5 - 7, 2014 at the Hyatt Regency Crystal City in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).

OTHER KEYNOTE SPEAKERS

Margaret (Peg) Hutchinson, Esq.
Assistant US Attorney, Civil Division, United States Attorney's Office, Eastern District of Pennsylvania, Philadelphia, PA




Roann Nichols, Esq.
Assistant US Attorney, United States Attorney's Office, District of Maryland, Baltimore, MD

Robert Patten, Esq.
Assistant Attorney General, Medicaid Fraud Division, The Commonwealth of Massachusetts, Co-chair, Global Case Committee, National Association of Medicaid Fraud Control Units, Holliston, MA
CHIEF COMPLIANCE OFFICER ROUNDTABLE

Christine Mikail, Esq.
Executive Vice President, General Counsel and Chief Compliance Officer, Dendron, New York, NY

Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharmaceuticals; Former Vice President and Assistant General Counsel, Merck, Stamford, CT

Caroline West, Esq.
Senior Vice President, Chief Compliance and Risk Officer, Shire Pharmaceuticals, Inc., Former Vice President, Global Legal Compliance, Aventis, Philadelphia, PA
FEATURED SESSION: SUNSHINE FOR MEDICAL DEVICE MANUFACTURERS

Kevin Dill, Esq.
Chief Compliance Officer, Olympus Corporation of the Americas, Philadelphia, PA

Nate Hwang, Esq.
Chief Compliance Officer, Zimmer, Inc., Fort Wayne, IN

Christopher L. White, Esq.
Senior Executive Vice President, General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC

Seth H. Lundy, Esq.
Partner, King & Spalding, Washington, DC (Moderator)
FEATURING A DISCLOSURE BASICS PRECONFERENCE

MINI SUMMITS
  • Technology Solutions
  • Practical Approaches to Global Transparency
  • Fair Market Value
  • Sunshine for Medical Device Manufacturers
  • Will Sunshine Data be Helpful to Whistleblowers and Qui Tam Attorneys?
DISCLOSURE SUMMIT IS

AND PLENARY SESSIONS
  • Sunshine Act Implementation Update
  • Chief Compliance Officer Roundtable
  • March 31st Filing Deadline: The Top Six Steps to do to Prepare
  • Assumptions and Completing Context Boxes: To Do or not to Do; That is the Question
  • Managing the Dispute Resolution Process
  • Coordination of Compliance amongst Multiple Affiliates
  • Interaction and Coordination between State and Federal Reporting Requirements
  • Challenges and Best Practices in Reporting Clinical Spend
  • Transactions Reviews for Non-CIA Organizations
  • Protecting the Reputation and Relationships with Physicians and Teaching Hospitals
  • Global Challenge: Conducting Background Checks on the HCPs/HCOs
  • Roundtable on Global Transparency: A Country by Country Update
  • Best Practices in Implementing a Coordinated Global Transparency Program
CO-LOCATED WITH
TWENTY SECOND NATIONAL HIPAA SUMMIT
A Hybrid Conference and Internet Event
The Leading Forum on Healthcare EDI, Privacy, Breach Notification, Confidentiality, Data Security and HIPAA Compliance
Media Partners: Harvard Health Policy Review and Health Affairs
February 5 - 7, 2014, Hyatt Regency Crystal City, Washington, DC
www.HIPAASummit.com


CO-LOCATED WITH
FIRST NATIONAL PHARMA, DEVICE
AND LIFE SCIENCES PRIVACY AND
CYBERSECURITY SUMMIT
A Hybrid Conference and Internet Event
The Leading Forum on Privacy and Security for Drug, Device and Biotech Companies
Sponsored by Pharmaceutical Compliance Forum
Co-sponsored by Centre for Information Policy Leadership (CIPC), International Pharmaceutical Privacy Consortium (IPPC), Medical Device Privacy Consortium (MDPC) and National Health ISAC (NH-ISAC) February 4 - 6, 2014, Hyatt Regency Crystal City, Washington, DC
www.LifeSciencePrivacyandSecurity.com

ASSUMPTIONS AND COMPLETING CONTEXT BOXES

Meenakshi Datta, Esq.
Partner, Sidley Austin LLP, Chicago, IL




Angela Fifelski, Esq.
Corporate Counsel, Regulatory Law, Baxter Healthcare Corporation, Deerfield, IL
MANAGING THE DISPUTE RESOLUTION PROCESS




Julie Brubaker, Esq.
Compliance Officer, Biomet Warsaw Operations; Former Deputy Solicitor General, Indiana Attorney General, Warsaw, IN

Ronald L. Wisor, Jr., Esq.
Partner, Hogan Lovells US LLP, Washington, DC
INTERACTION AND COORDINATION BETWEEN STATE AND
FEDERAL REPORTING REQUIREMENTS

Diane E. Bieri, Esq.
Partner, Arnold & Porter, Former Executive Vice President and General Counsel, Pharmaceutical Research and Manufacturers of America (PhRMA), Washington, DC

Trudy J. Seeley
Senior Manager, Transparency Operations, Sanofi US, Bridgewater, NJ
COORDINATION OF COMPLIANCE AMONGST MULTIPLE AFFILIATES

Cheryl Gutowski
Associate Director, Integrity and Compliance, Novartis Vaccines and Diagnostics, Boston, MA

Jon Wilkenfeld, MBA
President, Potomac River Partners, Vienna, VA
TRANSACTIONS REVIEWS FOR NON-CIA ORGANIZATIONS

Gus Papandrikos, MBA
Director of Compliance, Daiichi Sankyo, Former Director Transparency Operations, sanofi-aventis, New York, NY

Jack T. Tanselle
Managing Director, Healthcare Dispute Compliance and Investigation Practice, Navigant Consulting, Inc., Indianapolis, IN
FAIR MARKET VALUE UPDATE

Eve M. Brunts, Esq.
Partner, Ropes and Gray, Boston, MA

Mark A. DeWyngaert, MBA, PhD
Managing Director, Huron Consulting Group, New York, NY (Moderator)
PROTECTING REPUTATION AND RELATIONSHIPS WITH
PHYSICIANS AND TEACHING HOSPITALS

Julia Galperin, Esq.
Director, Commercial Compliance Operations, Genentech, South San Francisco, CA

Andrew Rosenberg, Esq.
Co-Founder, Thorn Run Partners, Former Staff, Senate Health, Education, Labor and Pensions Committee, US Senate, Washington DC



Sylvia J. Trujillo, MPP, JD
Legislative Counsel, Senior Attorney, Legislative Counsel Division, American Medical Association; Former Litigation Attorney, Office of the General, Centers for Medicare and Medicaid Services, Washington, DC

Thomas Sullivan
President, Rockpointe Corporation, Editor, Policy and Medicine, Columbia, MD
TECHNOLOGY SOLUTIONS

Michael D. Bell, Esq.
Founder and President, R-Squared, Princeton, NJ

Susan Hill
Senior Vice President, Business Development, AHM, Philadelphia, PA

John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ

Dean Rossi
Founder and President, Alanda, New Brunswick, NJ

Don Soong
Vice President of Strategic Solutions, Cegedim Relationship Management, Richmond, VA
GLOBAL CHALLENGE: CONDUCTING BACKGROUND CHECKS ON HCPs/HCOs

Ronny Arijs
Vice President Global Sustainability and Chief Compliance Officer, Grunenthal, Member, EFPIA Compliance Workgroup, Former Senior Compliance Manager, GE Healthcare, Brussels, Belgium

Andy Bender, MS, MBA
President, Polaris, New York, NY
CASE STUDY IN IMPLEMENTING A GLOBAL TRANSPARENCY SOLUTION

William E. Buzzeo, MS
Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA

Michael O'Connor
Executive Director, IS Business Consulting, Boehringer Ingelheim, New York, NY
PRACTICAL APPROACHES TO GLOBAL TRANSPARENCY COMPLIANCE

Sujata Dayal, JD, LLM
Vice President Health Care Compliance and Privacy, Pharmaceuticals, Johnson & Johnson, Former, Global Chief Compliance Officer and Corporate Vice President, Biomet, Inc., Former Ethics and Compliance Officer - Pharmaceutical Products, Abbott Laboratories, Chicago, IL

Ashish Kalgaonkar, RPh, MBA
Senior Director, Global HCP Transparency Reporting, Eli Lilly and Company, Indianapolis, IN

Michael D. Petty, Esq.
Partner, King & Spalding LLP; Former Vice President of Development and Regulatory Law, Amgen Inc., Washington, DC

Carolyn Bruguera, Esq.
Vice President, Consulting Services and General Counsel, R-Squared; Former Vice President and General Counsel, Hansen Medical, Princeton, NJ (Moderator)
FEATURED FACULTY

Jonathan Bach
Partner, Cooley, LLP, New York, NY

Sarah K. diFrancesca, Esq.
Associate, Health Care & Life Sciences, Regulatory Practice, Cooley, LLP, New York, NY

Jonathon Kellerman
Principal, Pharmaceutical and Life Sciences Advisory Services, PwC, Florham Park, NJ

Bharathram Lakshmivarahan
Director, Pharmaceutical & Life Sciences Advisory, PwC, Philadelphia, PA

Troy Morgan
Director, Corporate Compliance for R&D and PO&T, Biogen Idec, Weston, MA

Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC

Rajiv Shah
Director, Pharmaceutical & Life Science Advisory Services, PwC, New York, NY

Sarah Volden
Manager, Pharmaceutical & Life Science Advisory Services, PwC, Los Angeles, CA

SPECIAL PCF DISCOUNTS AVAILABLE
Special Pharmaceutical Compliance Forum (PCF) member registration discounts are available.
Click here to register.


UPDATED BROCHURE AVAILABLE
Click here to download brochure.
SPONSORED BY


CO CHAIRS

Margaret K. Feltz, Esq.
Director, Corporate Compliance, Purdue Pharma LP, Executive Committee, Pharmaceutical Compliance Forum, Stamford, CT

Ashish Kalgaonkar, RPh, MBA
Senior Director, Global HCP Transparency Reporting, Eli Lilly and Company, Indianapolis, IN

Trudy J. Seeley
Senior Manager, Transparency Operations, Sanofi US, Bridgewater, NJ

CONTINUING EDUCATION CREDITS
Compliance Professionals: Up to 23.4 Live CCB CEUs.

Accounting Professionals: Up to 24 NASBA CPE credits

Attorneys: Approved to offer a maximum of 20.0 Hours of Texas CLE Credits.

Attorneys: The Summit is currently pending approval to offer California and Pennsylvania MCLE Credit.

Click here for more information.

TUITION SCHOLARSHIPS
The Disclosure Summit supported by generous grants from the Heritage Provider Network is now offering partial and full Tuition Scholarships to qualifying representatives of local, state and federal government, consumer advocate organizations, safety net providers, academics, students and health services research organizations.
Click here for more information.

SUPPORTED BY

MEDIA PARTNERS






GRANTORS
GOLD


SILVER


BRONZE





























FOLLOW US ON






PARTICIPATION OPTIONS
TRADITIONAL CONFERENCE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction



LIVE AND ARCHIVED WEBCAST ATTENDANCE
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office



WEBCAST INTERFACE SAMPLE

Click here for a sample stream



SIXTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND
AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES

A Pharma Congress Conference
February 5 - 7, 2014

ATTEND ONSITE
Hyatt Regency Crystal City
Washington, DC


OR
WEBCAST PARTICIPATION
In your own office or home live via the Internet
with 24/7 access for six months




SAVE THE DATES

FIRST NATIONAL LIFE SCIENCES PRIVACY
AND SECURITY SUMMIT

A Hybrid Conference and Internet Event
The Leading Forum on Privacy and Security for Drug, Device and Biotech Companies
Co-located with Twenty Second National HIPAA Summit and Sixth Disclosure Summit
Media Partners: Harvard Health Policy Review and Health Affairs
February 4 - 6, 2014
Hyatt Regency Crystal City
Washington, DC
www.LifeSciencePrivacyandSecurity.com
SEVENTH INTERNATIONAL PHARMACEUTICAL
COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 5 - 7, 2014
Conrad Dubai
Dubai, United Arab Emirates
www.InternationalPharmaCongress.com
SECOND LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Latin American Ethics and Compliance Network
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
July 28 - 31, 2014
Mexico City, Mexico
www.LatinAmericanPharmaCongress.com
FOURTH ASIA PACIFIC PHARMACEUTICAL
COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
September, 2014
Beijing, China
www.AsianPharmaCongress.com
FIFTEENTH PHARMACEUTICAL REGULATORY
AND COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Transformational Learning - Effective Knowledge Exchange
Sponsored by Pharmaceutical Compliance Forum
November 3 - 5, 2014
Hyatt Regency on Capitol Hill
Washington, DC
www.PharmaCongress.com

SUMMIT REGISTRATION

For Summit registration information, visit www.DisclosureSummit.com/registration.php, email registration@hcconferences.com, or call 800-503-0112.


SUMMIT EXHIBIT & SPONSORSHIP INFORMATION

For sponsorship and exhibit information, visit www.DisclosureSummit.com/promotional/index.html, or contact Justin Sorensen, Exhibit Manager, at (206) 452-0609 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.